Antibacterial antibody and use thereof
The present invention relates to in a monoclonal antibody produced by CpG-DNA, or a functional fragment thereof, the monoclonal antibody, or functional fragment thereof, characterized in that it comprises polypeptide sequence selected from the group consisting of the following polypeptide sequences a heavy chain comprising a complementarity determining region 1 (CDR 1) amino acid sequence consisting of the sequence of SEQ ID NO: 1, a CDR2 consisting of the sequence of SEQ ID NO: 2 and a CDR 3 consisting of the sequence of SEQ ID NO: 3; and a light chain comprising CDR1 amino acid sequence consisting of the sequence of SEQ ID NO: 4, a CDR2 consisting of the sequence of SEQ ID NO: 5 and a CDR 3 consisting of the sequence of SEQ ID NO: 6 and a use of the same.
1. A monoclonal antibody specifically binding to S. aureus NW2, said monoclonal antibody comprising:
a heavy chain comprising a complementarity determining region 1 (CDR 1) amino acid sequence consisting of the sequence of SEQ ID NO: 1, a CDR2 consisting of the sequence of SEQ ID NO: 2 and a CDR 3 consisting of the sequence of SEQ ID NO: 3; and
a light chain comprising CDR1 amino acid sequence consisting of the sequence of SEQ ID NO: 4, a CDR2 consisting of the sequence of SEQ ID NO: 5 and a CDR 3 consisting of the sequence of SEQ ID NO: 6.
2. The monoclonal antibody of claim 1 , wherein said monoclonal antibody comprises
a heavy chain comprising an amino acid sequence consisting of the sequence of SEQ ID NO: 7, or the sequence of SEQ ID NO: 15; and
a light chain comprising an amino acid sequence consisting of the sequence of SEQ ID NO: 8, or the sequence of SEQ ID NO: 16.
3. An antimicrobial composition comprising a monoclonal antibody specifically binding to S. aureus NW 2, said monoclonal antibody comprising:
a heavy chain comprising a complementarity determining region 1 (CDR 1) amino acid sequence consisting of the sequence of SEQ ID NO: 1, a CDR2 consisting of the sequence of SEQ ID NO: 2 and a CDR 3 consisting of the sequence of SEQ ID NO: 3; and
a light chain comprising CDR1 amino acid sequence consisting of the sequence of SEQ ID NO: 4, a CDR2 consisting of the sequence of SEO ID NO: 5 and a CDR 3 consisting of the sequence of SEQ ID NO: 6 as an active ingredient.
4. The composition of claim 3 , wherein the composition has antibacterial activity against Gram-positive bacteria, Gram-negative bacteria, intracellular parasitic bacteria, or drug-resistant bacteria.
5. The composition of claim 3 , wherein the composition has antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus aureus, Listeria, Salmonella , or E. coli.